tPA (Alteplase) Dosing for Ischemic Stroke Calculator
ورودیهای بالینی بیمار
حداقل ۳۰ — حداکثر ۲۰۰ • واحد: kg
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Standard Dosing0–90
- Maximum Dose90–90
The tPA (Alteplase) Dosing for Ischemic Stroke Calculator calculator is designed for bedside calculating alteplase dose for ischemic stroke treatment using weight-based dosing protocol with bolus and infusion components in clinical practice. The resulting score directly guides clinician decision-making regarding determining acute hospital admission, emergency.
Clinical Guidelines & Evidence
Calculates alteplase dose for ischemic stroke treatment using weight-based dosing protocol with bolus and infusion components
Clinical Indication
The tPA (Alteplase) Dosing for Ischemic Stroke Calculator is indicated for bedside clinical practice to support Calculates alteplase dose for ischemic stroke treatment using weight-based dosing protocol with bolus and infusion components. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult and pediatric patients presenting with acute undifferentiated clinical complaints, trauma, or unstable vital signs. Clinical application is indicated across Emergency triage, acute resuscitation bays, observation units, and emergency trauma centers.
Limitations & Contraindications
Score calculations must never delay immediate life-saving airway stabilization, vascular access, or emergent surgical consult. Clinical exclusion: Do NOT use for acute coronary syndrome or pulmonary embolism.
Clinical Pearls & Action Plan
Adherence to core ABCDE resuscitation principles and bedside clinical gestalt must take absolute precedence over numerical decision tools.
Total Dose (mg) = 0.9 × Weight (kg), maximum 90 mg. Bolus = 10% of total dose over 1 minute. Infusion = 90% of total dose over 60 minutes.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| weight | float | Yes | Patient weight in kilograms(kg) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–90 | Standard Dosing | Weight-based dosing at 0.9 mg/kg |
| 90–90 | Maximum Dose | Maximum dose cap reached |
Evidence-Based References (EBM)
- The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995 Dec 14;333(24):1581-7. doi: 10.1056/NEJM199512143332401.DOI: 10.1056/NEJM199512143332401
- Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.DOI: 10.1056/NEJMoa0804656
- Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. Stroke. 2019 Dec;50(12):e344-e418. doi: 10.1161/STR.0000000000000211.DOI: 10.1161/STR.0000000000000211